NCAPD3

Condensin-2 complex subunit D3 · P42695 · NCAPD3 on Sugi Atlas →

0 patent compounds predicted against NCAPD3, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to NCAPD3 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
PhII 5-Azacytidine Plus Valproic Acid and Eventually Atra in Intermediate II and High Risk MDS PHASE2COMPLETED
Trial of the Histone-Deacetylase Inhibitor ITF2357 Followed by Mechlorethamine in Relapsed/Refractory Hodgkin's Lymphoma PHASE1/PHASE2COMPLETED
Psychopharmacology for Cocaine Dependence - Buspirone PHASE2COMPLETED
Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients nanCOMPLETED
Quantitative Assessment of the Etiologies of Megalencephaly Associated With a Detectable Tumor Risk nanNOT_YET_RECRUITING
Molecular Studies on the Candidate Genes of Dopaminergic and Noradrenergic Systems in ADHD nanCOMPLETED
The 3q29 Deletion and 3q29 Duplication: Architecture of Behavioral Phenotypes nanRECRUITING
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 nanCOMPLETED
Clinical and Genetic Analysis in Congenital Hypothyroidism Due to Thyroid Dysgenesis. nanCOMPLETED
Autophagy in Systemic Lupus Erythematosus nanUNKNOWN
Identification of Genetic Basis of Atrioventricular Conduction Defects: From Congenital Forms to Degenerative Forms nanUNKNOWN
Corpus Callosum Agenesis and Intellectual Disability nanCOMPLETED
Better Delineation of CDK13 Related Phenotype and Epigenetic Signature. nanUNKNOWN
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM) nanCOMPLETED
Investigating Phenotypic, Epigenetic, and NeuroGenetic Traits in Rare and Ultra-rare Neurodevelopmental Disorders (Project PENGUIN) nanRECRUITING
Genetic, Dietary and Environmental Influences on Vitamin D Metabolism nanCOMPLETED
PCD New Gene Discovery nanCOMPLETED
Genetic Studies of Strabismus, Congenital Cranial Dysinnervation Disorders (CCDDs), and Their Associated Anomalies nanRECRUITING
The Effect Of Vitamin D On Measures Of Bone Health And Gene Expression nanCOMPLETED
Family Blood Pressure Program - HyperGEN nanCOMPLETED
Prognostic Value of Vitamin D Levels in Egyptian Females With Breast Cancer nanUNKNOWN
Gene Expression, Metabolomic, Microbiome, and Calcium Metabolism in Response to Varied Vitamin D Dosages nanCOMPLETED
Pathogenesis of Primary Ciliary Dyskinesia (PCD) Lung Disease nanRECRUITING
Velocardiofacial (VCFS; 22q11.2; DiGeorge) Syndrome Study nanCOMPLETED
Nuclear Myosin VI - a Therapeutic Target in Breast Cancer nanUNKNOWN
Diagnosis of Primary Ciliary Dyskinesia nanCOMPLETED
The Contribution of Optical Mapping to the Characterization of Chromosomal Rearrangements in Patients With Neurodevelopmental Disorders nanRECRUITING
MD2, Cystatin C and DNA Methylation Tags as Serum Biomarkers for POCD. nanUNKNOWN
Study of the Genetic Factors Involved in Autism and Related Disorders nanRECRUITING
The Impact of Selective Vitamin D Receptor Activation on Clinical Outcomes in Septic Patients nanNOT_YET_RECRUITING

Related proteins — ESM-2 sequence neighbours (a NCAPD3 binder may also engage these)

ProteinNameSimilarity
Q6ZQK0 1.000 Q6ZQK0 →
Q6GN08 0.999 Q6GN08 →
Q3UHQ6 0.997 Q3UHQ6 →
Q6PR54 0.997 Q6PR54 →
Q5JWR5 0.997 Q5JWR5 →
Q5PQS3 0.997 Q5PQS3 →
Q8H0T4 0.996 Q8H0T4 →
Q14D04 0.996 Q14D04 →
Q9Y3R5 0.996 Q9Y3R5 →
Q640K1 0.996 Q640K1 →
Q2TAW0 0.996 Q2TAW0 →
Q5XG71 0.995 Q5XG71 →
E1C231 0.995 E1C231 →
Q91VB4 0.995 Q91VB4 →
Q5ZLS8 0.995 Q5ZLS8 →
Q6DFV1 0.994 Q6DFV1 →
Q4V9P9 0.994 Q4V9P9 →
Q86XI2 0.994 Q86XI2 →
Q6GPP1 0.994 Q6GPP1 →
Q8BJW5 0.994 Q8BJW5 →
Q3URQ0 0.994 Q3URQ0 →
Q19317 0.993 Q19317 →
Q6A009 0.993 Q6A009 →
Q5ZM41 0.993 Q5ZM41 →
E7FH61 0.993 E7FH61 →
F4IP13 0.993 F4IP13 →
Q6TNU3 0.993 Q6TNU3 →
F1QN74 0.993 F1QN74 →
P97313 0.993 P97313 →
Q8WUM0 0.993 Q8WUM0 →